937.70
+6.40
+(0.69%)
At close: March 3 at 5:21:36 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 34 | 33 | 44 | 43 |
Avg. Estimate | 10.5B | 10.9B | 44.3B | 49.68B |
Low Estimate | 10.41B | 10.68B | 43.51B | 47.98B |
High Estimate | 10.9B | 11.41B | 45.86B | 53.11B |
Year Ago Sales | 9.37B | 9.56B | 39B | 44.3B |
Sales Growth (year/est) | 12.04% | 14.05% | 13.60% | 12.12% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
1NFLX.MI | -- | -- | -- | -- |
S&P 500 | 16.04% | 7.30% | 10.62% | 14.21% |
Upgrades & Downgrades
Upgrade | Wolfe Research: Peer Perform to Outperform | 1/23/2025 |
Maintains | UBS: Buy to Buy | 1/22/2025 |
Maintains | Goldman Sachs: Neutral to Neutral | 1/22/2025 |
Reiterates | Piper Sandler: Overweight to Overweight | 1/22/2025 |
Maintains | Keybanc: Overweight to Overweight | 1/22/2025 |
Maintains | Oppenheimer: Outperform to Outperform | 1/22/2025 |